Liver Cancer Trial, Recruiting NCT06341270 Sponsor: West China Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06341270
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 80 years old
  • People rated as generally healthy to moderately unwell before surgery, based on a standard medical fitness scale (ASA Class I–III)
  • People who are scheduled for a planned (non-emergency) liver removal surgery

Who may not be able to join:

  • People who have a history of epilepsy
  • People who have a rash or skin infection in the area where acupoint stimulation would be applied
  • People who are pregnant or breastfeeding
  • People who have an intellectual disability, or a psychiatric or neurological condition
  • People who are unable to use a simple number-based pain rating scale
  • People who have an implanted cardiac pacemaker, cardioverter, or defibrillator
  • People who regularly use opioid pain medications on an ongoing basis
  • People whose cancer has spread to other organs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chunling Jiang, PhD, West China Hospital

Phone: 18980601096

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
West China Hospital
Registry
ClinicalTrials.gov
Start date
6 May 2024
Est. completion
20 April 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence of moderate to severe pain (NRS ≥ 4) during movement (i.e. cough or take three deep breaths) at 24 hours after surgery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov